People with insulin resistance or metabolic syndrome may see better results as the medication improves these conditions alongside weight loss
Free fatty acids enter circulation and are taken up by liver, muscle, and other tissues for beta-oxidation

Food & Drug Administration (2024) One-year weight reduction with semaglutide or liraglutide in clinical practice, Diabetes and Endocrinology (2024) Semaglutide vs tirzepatide for weight loss in adults with overweight or obesity, JAMA Internal Medicine (2024) Anti-inflammatory benefits of semaglutide: State of the art, Journal of Clinical and Translational Endocrinology (2024) Fight inflammation to help prevent heart disease, Johns Hopkins Medicine Body weight and blood pressure regulation, The American Journal of Clinical Nutrition (1996) Semaglutide and cardiovascular outcomes in patients with Type 2 diabetes, The New England Journal of Medicine (2016) Once-weekly semaglutide in adults with overweight or obesity, The New England Journal of Medicine (2021) Semaglutide, StatPearls (2024) Heart failure medications, Cleveland Clinic (2022) Research shows GLP-1 receptor agonist drugs are effective but come with complex concerns, UChicago Medicine (2024) Efficacy and safety of GLP-1 medicines for Type 2 diabetes and obesity, Diabetes Care (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

Learn more about how insurance coverage works with Mochi here